Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pharmacielo Ltd V.PCLO

Alternate Symbol(s):  PCLOF

PharmaCielo Ltd. is a Canada-based global company with a focus on ethical and sustainable cultivating, processing and supply of all natural, pharmaceutical-grade medical dried cannabis flower and cannabis products to large channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo... see more

Recent & Breaking News (TSXV:PCLO)

PharmaCielo Ltd. Closes $4.6 Million Bought Deal Offering

Canada NewsWire July 3, 2020

PharmaCielo Ltd. Files Final Prospectus for $4 Million Bought Deal Offering

Canada NewsWire June 29, 2020

PharmaCielo Ltd. Announces $4,000,000 Bought Deal Public Offering

Canada NewsWire June 10, 2020

PharmaCielo Announces Financial Results for the First Quarter Ended March 31, 2020 and Provides Operational Update

Canada NewsWire June 1, 2020

PharmaCielo Ltd. Obtains Final Receipt for Short Form Prospectus

Canada NewsWire May 15, 2020

PharmaCielo Welcomes Dr. Claudia Jiménez to Board of Directors

Canada NewsWire May 12, 2020

PharmaCielo Adds Experienced Senior Leader to Executive Team

Canada NewsWire May 4, 2020

PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2019

Canada NewsWire April 30, 2020

PharmaCielo Provides Details for Fourth Quarter and Year-End 2019 Results Conference Call

Canada NewsWire April 29, 2020

PharmaCielo Ltd. Announces Closing of Previously Announced $8 Million Private Placement Financing

Canada NewsWire April 15, 2020

PharmaCielo Ltd. Prices $8 Million Offering; Closing Scheduled for April 14

Canada NewsWire April 6, 2020

PharmaCielo Ltd. Announces Best Efforts Private Placement Offering

Canada NewsWire April 1, 2020

PharmaCielo Independent Investigation Concludes Short-seller Report Contains Accusations and Claims based on Faulty Interpretation of Events and Information

Canada NewsWire March 23, 2020

PharmaCielo Issues Statement Regarding Misleading Short Seller Report

Canada NewsWire March 3, 2020

XPhyto Therapeutics Announces Strategic Supply, Import and Distribution Agreement for the German Cannabis Market

Newsfile January 27, 2020

PharmaCielo Announces 30,000 Kg Cannabis Extract Agreement for German Market

Canada NewsWire January 27, 2020

PharmaCielo Signs Pan-European Distribution Agreement for CBD Isolate and Broad-Spectrum CBD Oil

Canada NewsWire January 24, 2020

PharmaCielo Added to XCAN - the Newly Created S&P/TSX Cannabis Index

Canada NewsWire January 22, 2020

PharmaCielo Becomes First Cultivator Awarded Good Agricultural Practices (GAP) Global Certification for Colombian Medicinal-Cannabis Operations

Canada NewsWire January 20, 2020

PharmaCielo Receives Acceptance from TSX Venture Exchange of Supply Agreement for Export of 2018 Farm Bill Compliant CBD Isolate to United States

Canada NewsWire January 17, 2020